M. Fedyanin, L. Vladimirova, N. A. Abramova, A. E. Storozhakova, I. Popova, N. Tikhanovskaya, E. A. Kalabanova, Е. Panina, A. Arzamastseva, E. Rybakov, L. Bolotina, T. V. Ustinova, А. А. Kachmazov, I. Pokataev, A. Tryakin, O. Sekhina, D. Chekini, Kheda Elsnukaeva, D. V. Podluzhniy, S. Tjulandin, O. Kit
{"title":"接受化疗和抗egfr抗体的不可切除转移性结直肠癌患者的转移性切除术:一项前瞻性、非随机、多中心、II期研究","authors":"M. Fedyanin, L. Vladimirova, N. A. Abramova, A. E. Storozhakova, I. Popova, N. Tikhanovskaya, E. A. Kalabanova, Е. Panina, A. Arzamastseva, E. Rybakov, L. Bolotina, T. V. Ustinova, А. А. Kachmazov, I. Pokataev, A. Tryakin, O. Sekhina, D. Chekini, Kheda Elsnukaeva, D. V. Podluzhniy, S. Tjulandin, O. Kit","doi":"10.17650/2220-3478-2019-9-1-65-72","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":225735,"journal":{"name":"Colorectal Oncology","volume":"03 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study\",\"authors\":\"M. Fedyanin, L. Vladimirova, N. A. Abramova, A. E. Storozhakova, I. Popova, N. Tikhanovskaya, E. A. Kalabanova, Е. Panina, A. Arzamastseva, E. Rybakov, L. Bolotina, T. V. Ustinova, А. А. Kachmazov, I. Pokataev, A. Tryakin, O. Sekhina, D. Chekini, Kheda Elsnukaeva, D. V. Podluzhniy, S. Tjulandin, O. Kit\",\"doi\":\"10.17650/2220-3478-2019-9-1-65-72\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":225735,\"journal\":{\"name\":\"Colorectal Oncology\",\"volume\":\"03 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colorectal Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17650/2220-3478-2019-9-1-65-72\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17650/2220-3478-2019-9-1-65-72","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Metastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study